A panel of eight neutralizing monoclonal antibodies (MAbs) against the fusion (F) protein of Newcastle disease virus (NDV) has been shown to locate a major antigenic site on the basis of competitive binding assay and additivity index studies. Five epitopes (A 1 to AS) have been located within this site on the F protein of the Beaudette C strain of NDV on the basis of cross-resistance plaque assays of MAb-resistant mutants raised against these MAbs. Epitopes A1, A4 and A5 are distinct; epitope A2 partially overlaps epitope A3. Nucleotide sequence analysis of the F genes of MAbresistant mutants showed that each predicted single amino acid substitutions ranging from amino acid residues 157 to 171 for epitope A4 and at residues 72, 78, 79 and 343 for epitopes A 1, A2, A3 and A5 respectively. These locations indicate that both the F 1 and F2 fragments are involved in the formation of a single antigenic site and suggest the involvement of extensive protein folding in the active form of this F protein.
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There are two surface glycoproteins in the envelope of the avian paramyxovirus Newcastle disease virus (NDV). The haemagglutinin-neuraminidase (HN) glycoprotein mediates the attachment of the virus to cell surface receptors and the fusion (F) glycoprotein is responsible for cell-to-cell fusion, haemolysis, and virus penetration (Scheid & Choppin, 1974; Merz et al., 1981) . Proteolytic cleavage of the inactive F0 precursor into two disulphide-linked subunits, F1 and F2, is necessary for infection in vivo (Samson & Fox, 1973; Nagai et al., 1976; Scheid & Choppin, 1977) . Conformational changes have been shown to occur just prior to this cleavage event (McGinnes et al., 1985) . It has been suggested that the N-terminal region of the F1 fragment brings about membrane fusion by hydrophobic interaction with the cellular membrane (Gething et al., 1978; Richardson et al., 1980) . A panel of eight monoclonal antibodies (MAbs) was used in this study. Anti-F MAbs 1C3, 2C1, 8B1 and 12C4 were described by Le Long et al. (1986) and MAbs U23, U69, U70 and U79 each bind to the F protein of strain Ulster 2C (D. J. Alexander & M. S. Collins, unpublished data). The eight MAbs also bind to virions of the Beaudette C strain when assayed by ELISA (not shown).
The MAbs were purified from ascites fluids, labelled with peroxidase as described (Yusoff et al., 1988) and used in reciprocal competitive binding assays using wild-type Beaudette C virions to determine whether or not these antibodies recognize distinct sites on the F protein. As indicated in Table I (Nishikawa et al., 1983) . t ND, Not determined. same antigenic site (site A). In contrast, the NDV HN protein has at least three antigenic sites (Yusoff et al., 1988) .
Several independent mutants that were resistant to the panel of MAbs were isolated in the Beaudette C strain and used in cross-resistance plaque assays. On the basis of the inability of these mutants to be neutralized by other MAbs, five epitopes could be distinguished. As shown in Table 2 , all MAb-resistant mutants were no longer neutralized by their respective selecting MAbs. Furthermore, MAbs, 8B1 and U23 failed to neutralize all 2Cl-resistant mutants and MAbs U69, U70 and U79 failed to neutralize all U69-and U70-resistant mutants. However, U79-resistant mutants were still neutralized by MAb U70. Therefore, we place MAb 1C3 in epitope group A1, MAbs 2C1 and 8B1 in epitope group A2, MAb U23 in epitope group A3, MAbs U69, U70 and U79 in epitope group A4, and MAb 12C4 in epitope group A5.
In order to map these neutralizing epitopes within the amino acid sequence of the NDV F protein, the entire F genes of the mutants as well as of the wild-type strain were sequenced directly from the genomic RNA using reverse transcriptase (Yusoff et al., 1988) . The nucleotide sequence of the wild:type F gene obtained from our sequence studies was identical to the et al., 1986) except for a mutation from T to C at the redundant third base position in the Ser (307) codon, TCT to TCC. Apart from this, only one nucleotide change from the wild-type sequence was found for each mutant sequenced. The deduced amino acid substitutions are given in Table 3 . MAbs 2C1 and 8B1 were originally generated using NDV strains La Sota and Italien respectively (Le Long et al., 1986) . All the Beaudette C escape mutants selected with MAbs 2C 1 and 8B1 displayed identical single point mutations from Lys (78) to Glu (non-conservative); moreover, Beaudette C escape mutants selected with either MAb are cross-resistant to the other MAb ( Table 2 ). The sequence changes confirm that they both recognize the same epitope, A2. The recent study by Neyt et al. (1989) with NDV Italien has shown that MAbs 2C1 and 8B1 select escape mutants that map to amino acid residues 74 and 75 respectively and which are no longer neutralized by either MAb. The slight discrepancy in amino acid position for escape mutants generated using the same MAbs may reflect either subtle differences in the F protein conformation between the two different strains or the fact that only a limited number of independent escape mutants has yet been sequenced. The discrepancy in amino acid position for escape mutants generated with MAb 2C1 (position 74 for the Italien and position 78 for the Beaudette C strain) may account for the fact that MAb 1C3 fails to neutralize 2C1 escape mutants isolated from the Italien strain, but neutralizes 2C1 escape mutants isolated from the Beaudette C strain.
The amino acid changes for epitopes A1 and A3 were located very close to each other and to A2. The A 1 epitope had mutations at Asp (72) to either Gly or Tyr following selection with MAb 1C3. The former mutation had previously been observed by Toyoda et al. (1988) for NDV Sato and more recently by Neyt et al. (1989) for NDV Italien (in this case also using MAb 1C3). The A3 epitope had a change at Ala (79) to Thr. The A2 and A3 epitopes partially overlap each other (Table 2) .
Mutations in each of the above three epitopes (amino acid residues 72, 78 and 79), are located next to a major hydrophilic region of the F2 subunit, close to the only cysteine residue in F2 (Cys 76), which is necessarily involved in the disulphide linkage to FI (Fig. 1) .
The mutations in the A4 epitope extend from amino acids 157 to 171 and are located within a slightly hydrophilic region of the F1 protein. Mutant U79-1 had a change from Ser (157) to Asn; U79-2 had a change from Thr (161) to Ile; U69-1, U69-2 and U70-1 had changes from Asp (170) to Asn; U70-2 had a change from Gly (171) to Arg. The mutation at amino acid Thr (161) had been observed by Toyoda et al. (1988) for the Sato strain of NDV.
Finally, the A5 epitope was recognized only by MAb 12C4. Mutants resistant to this antibody (343) to Ser change in the Italien strain using MAb 12C4. In addition they obtained an Ala (378) to Val change when their 8B 1-resistant mutant was used to generate a second site mutant by selection with a mixture of MAbs 1 C3, 10F2 and 12C4. This second site mutation was ascribed to selection by 12C4. This fifth epitope is located within the cysteine cluster domain which has been suggested to play an important role in the secondary structure of the F proteins (Portner et al., 1987; Hull et al., 1987) .
In the light of the competitive binding assays, the difficulties in achieving Western blotting (not shown) and the escape mutant sequence data described here for the Beaudette C strain, and elsewhere for the Sato (Toyoda et al., 1988) and the Italien (Neyt et al., 1989 ) strains, we conclude that the antigenic structure of the NDV F protein (in so far as the neutralizing epitopes are concerned), is highly conserved and conformational in nature. This suggests that any subunit vaccine designed to protect birds by eliciting circulating antibodies would be better based upon the entire F protein rather than various synthetic peptides chosen from the F protein sequence.
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